Alvotech
ALVONASDAQHealthcare● Active
$3.97
+$0.43(+12.01%)
Market Cap$1.2B
P/E Ratio—
52W High$11.12
52W Low$2.94
Alvotech (ALVO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALVO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
-$0.09
Est. -$0.07 · -28.6%
Revenue
$0.11B
Est. $0.11B · -5.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
ALVO reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.04 | — | — | — | $0.14B | — |
| ▼ Q2 FY2026 | May 6, 2026 | -$0.07 | -$0.09 | -28.6% | $0.11B | $0.11B | -5.8% |
| ▼ Q1 FY2026 | Mar 18, 2026 | -$0.01 | -$0.37 | -6334.8% | $0.17B | $0.16B | +6.8% |
| ▼ Q4 FY2025 | Nov 12, 2025 | $0.05 | -$0.02 | -140.0% | $0.11B | $0.16B | -30.9% |
| ▲ Q3 FY2025 | Aug 13, 2025 | -$0.26 | $0.14 | +153.8% | $0.17B | $0.16B | +11.4% |
| ▲ Q2 FY2025 | May 7, 2025 | -$0.17 | $0.35 | +305.9% | $0.13B | $0.12B | +10.2% |
| ▲ Q1 FY2025 | Mar 26, 2025 | -$0.39 | -$0.24 | +38.5% | $0.15B | $0.10B | +54.3% |
| ▲ Q4 FY2024 | Nov 13, 2024 | -$0.06 | $0.19 | +401.6% | $0.49B | $0.09B | +476.1% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.04
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
-$0.09
EPS Est.
-$0.07
EPS Surpr.
-28.6%
Revenue
$0.11B
Q1 FY2026
Mar 18, 2026Miss
EPS Actual
-$0.37
EPS Est.
-$0.01
EPS Surpr.
-6334.8%
Revenue
$0.17B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.02
EPS Est.
$0.05
EPS Surpr.
-140.0%
Revenue
$0.11B
Q3 FY2025
Aug 13, 2025Beat
EPS Actual
$0.14
EPS Est.
-$0.26
EPS Surpr.
+153.8%
Revenue
$0.17B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.35
EPS Est.
-$0.17
EPS Surpr.
+305.9%
Revenue
$0.13B
Q1 FY2025
Mar 26, 2025Beat
EPS Actual
-$0.24
EPS Est.
-$0.39
EPS Surpr.
+38.5%
Revenue
$0.15B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
$0.19
EPS Est.
-$0.06
EPS Surpr.
+401.6%
Revenue
$0.49B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.00 | $-0.00 | $-0.00 | 1 |
| Q3 FY2027 | $0.07 | $0.08 | $0.09 | 1 |
| Q2 FY2027 | $0.07 | $0.08 | $0.10 | 1 |
| Q1 FY2027 | $0.05 | $0.06 | $0.07 | 1 |
| Q4 FY2026 | $0.14 | $0.16 | $0.18 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 2 |
| Q1 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2026 | $0.2B | $0.3B | $0.3B | 2 |
| Q3 FY2026 | $0.1B | $0.2B | $0.2B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -28.6% | $3.50 | $3.57 | +2.00% |
| ▼ Q1 FY2026 | Mar 18, 2026 | -6334.8% | $3.82 | $3.80 | -0.52% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -140.0% | $5.58 | $5.60 | +0.36% |
| ▲ Q3 FY2025 | Aug 13, 2025 | +153.8% | $8.65 | $8.96 | +3.58% |
| ▲ Q2 FY2025 | May 7, 2025 | +305.9% | $7.97 | $7.94 | -0.38% |
| ▲ Q1 FY2025 | Mar 26, 2025 | +38.5% | $11.66 | $11.55 | -0.94% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +401.6% | $12.16 | $11.93 | -1.89% |
| ▲ Q3 FY2024 | Aug 15, 2024 | +200.0% | $11.05 | $11.93 | +7.96% |
Q2 FY2026+2.00%
Report Date
May 6, 2026
EPS Beat/Miss
-28.6%
Price Before
$3.50
Price After
$3.57
Q1 FY2026-0.52%
Report Date
Mar 18, 2026
EPS Beat/Miss
-6334.8%
Price Before
$3.82
Price After
$3.80
Q4 FY2025+0.36%
Report Date
Nov 12, 2025
EPS Beat/Miss
-140.0%
Price Before
$5.58
Price After
$5.60
Q3 FY2025+3.58%
Report Date
Aug 13, 2025
EPS Beat/Miss
+153.8%
Price Before
$8.65
Price After
$8.96
Q2 FY2025-0.38%
Report Date
May 7, 2025
EPS Beat/Miss
+305.9%
Price Before
$7.97
Price After
$7.94
Q1 FY2025-0.94%
Report Date
Mar 26, 2025
EPS Beat/Miss
+38.5%
Price Before
$11.66
Price After
$11.55
Q4 FY2024-1.89%
Report Date
Nov 13, 2024
EPS Beat/Miss
+401.6%
Price Before
$12.16
Price After
$11.93
Q3 FY2024+7.96%
Report Date
Aug 15, 2024
EPS Beat/Miss
+200.0%
Price Before
$11.05
Price After
$11.93
Avg Beat Reaction+1.67%
Avg Miss Reaction+0.61%
Beat Rate5 / 8 quarters
Largest Move+7.96% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALVO ends December
Alvotech (ALVO) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $-0.09 — missing the analyst consensus of $-0.07 by -28.6%. The next ALVO earnings date is expected around September 1, 2026.
Each quarter, investors track ALVO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALVO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALVO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALVO earnings · 5 questionsAlvotech's next earnings report is expected around September 1, 2026. ALVO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALVO historically reports after market close (AMC).
ALVO earnings datewhen is ALVO earningsALVO next earnings datewhen does ALVO report earningsALVO earnings calendar
▸ Source: FMP · Alvotech SEC filings · US GAAP · Alvotech SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026